Glucagon-like peptide-1 receptor agonists and the diabetic foot: Mechanisms, clinical evidence, and practical considerations

Clinics in Dermatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles